Knowledge Center

56 Results Found

Having conversations with clinicians can be difficult, Howard Mann, a 30 year supply chain professional, discusses how to prepare for physician conversations regarding vendor consolidations to reduce the number of suppliers for product or product categories.
Allen Archer, director of supply chain management, Houston Hospitals, Inc., explains the basics of writing a contract including best practices and key tips.
Allen Archer, director of supply chain management, Houston Hospitals, Inc., describes five key terms and conditions that will assist you in writing a contract.
This Awareness Brief provides a quick reference to the Draft Guidance for UDI Convenience Kits, released by the FDA in January 2016. The draft guidance defines the term “convenience kit” for purposes of compliance with UDI labeling and data submission requirements only.
Background:In many locations across the country, cold weather or desert climates create dry environmental conditions.  In order to achieve the higher levels of humidity required by regulatory agencies, hospitals and ambulatory surgery centers have to add humidity into the building air, an activity that is expensive and creates its own unique set of challenges.
AHRMM is offering a repository for leading and proven supply chain practices, case studies, and toolkits that are developed from a Cost, Quality, and Outcomes (CQO) perspective. The following Catheter Acquired Urinary Tract Infections (CAUTI) leading practice was submitted by: Nexera, Inc., New York, NY
The Patient Protection and Affordable Care Act of 2010 (ACA) requires the Secretary of Health and Human Services to establish a VBP program to pay hospitals for their actual performance on quality measures, rather than just the reporting of those measures, beginning in fiscal year (FY) 2013. The VBP program will apply to all acute-care prospective payment system (PPS) hospitals. Read a summary of key provisions of the proposed rule.
AHRMM’s Issues & Legislative Committee issued the following Statement on Pricing Transparency approved by AHRMM Board of Directors:
The final regulations that provide guidance on the excise tax imposed on the sale of certain medical devices, enacted by the Health Care and Education Reconciliation Act of 2010 in conjunction with the Patient Protection and Affordable Care Act.
How to write a constructive, information-rich comment that clearly communicates and supports its claims to have an impact on regulatory decision making.
Supply chain must play an integral role in the care delivery process through cross-departmental partnerships that support evidence-based value analysis. Michael Louviere, System VP of Supply Chain at OHS shares his insights on what he calls a 'new adventureattempting to support best practices by collecting clinical evidence and synthesizing it to ensure that clinical practice is based on integrating individual clinical expertise with the best available relevant external clinical evidence from systematic research.
The Medical Device Excise Tax, a component of the Affordable Care Act, is approaching implementation at the beginning of 2013. The tax is intended to provide an estimated $20 billion in tax revenues to help pay for the expansion of health coverage to 32 million uninsured Americans. Healthcare supply chain leaders have until May 7, 2012, to comment on the way in which the Internal Revenue Service (IRS) intends to implement this new tax.
The medical device excise tax is a feature of the Affordable Care Act. It is important to be knowledgeable about the tax and its effects.